Clinical Trials Browser

Phase 3 × INDUSTRY × donafenib × Clear all

NCT02870582 2022-11-29

Donafenib for Previously Treated Metastatic Colorectal Cancer

Phase 3 Completed

Gastrointestinal

Colorectal Neoplasms

NCT03602495 2021-12-13

DTC

Phase 3 Terminated

EndocrineHead & Neck

Differentiated Thyroid Cancer